April 18, 2025 3:34 PM

Indian pharma giants target bigger share of $145 billion US cancer drug market

Indian pharmaceutical companies are ramping up efforts to expand their footprint in the lucrative US oncology generics market, currently valued at $145 billion and growing at a robust annual rate of 11 per cent, according to a new report. In recent months, several Indian drugmakers have secured approvals from the US Food and Drug Administration (FDA) for generic versions of cancer drugs, marking a steady increase in the entry of complex generics and biosimilars into the American market. With o...